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Triterpenes are structurally complex plant natural products with
numerous medicinal applications. They are synthesized through an
origami-like process that involves cyclization of the linear 30 carbon
precursor 2,3-oxidosqualene into different triterpene scaffolds. Here,
through a forward genetic screen in planta, we identify a conserved
amino acid residue that determines product specificity in triterpene
synthases from diverse plant species. Mutation of this residue results in
a major change in triterpene cyclization, with production of tetracyclic
rather than pentacyclic products. The mutated enzymes also use the
more highly oxygenated substrate dioxidosqualene in preference to
2,3-oxidosqualene when expressed in yeast. Our discoveries provide
new insights into triterpene cyclization, revealing hidden functional di-
versity within triterpene synthases. They further open up opportunities
to engineer novel oxygenated triterpene scaffolds by manipulating the
precursor supply.
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The triterpenes are one of the largest and most diverse groups ofplant natural products (1). These compounds have numerous
pharmaceutical, agricultural, and industrial biotechnology applica-
tions (2–5). The ability to harness this diversity to engineer known
and new-to-nature triterpenes would therefore be of considerable
value. Triterpenes, like sterols, are synthesized from the mevalonate
pathway via the linear 30-carbon precursor 2,3-oxidosqualene (OS)
(Fig. 1A) (2–6). The first committed step in sterol biosynthesis is
cyclization of OS to cycloartenol by cycloartenol synthase. In tri-
terpenoid biosynthesis, OS is converted to an array of alternative
cyclization products by other cyclase enzymes known as triterpene
synthases. The resulting scaffolds are often further elaborated by
oxidation and glycosylation to triterpene glycosides (also known as
saponins) (2–5). Currently, approximately 100 distinct triterpene
skeletons made from OS are known from diverse plant species, the
most common of which is the pentacyclic triterpene β-amyrin (1–3).
Homology modeling in combination with domain swapping and
site-directed mutagenesis using yeast as an expression system has
yielded insights into triterpene synthase function (e.g., refs. 7–11).
However, the mechanisms of triterpene cyclization are still only
poorly understood.
Oats (Avena species) produce antifungal triterpenes known as
avenacins. These β-amyrin–derived compounds are synthesized in
the root tips and provide protection against attack by soil-borne
pathogens (12, 13). The major avenacin A-1 is esterified with the
natural fluorophore N-methyl anthranilate (Fig. 1A) and is strongly
autofluorescent under ultraviolet light (13). We previously exploited
this feature to identify avenacin-deficient mutants of diploid oat
(Avena strigosa) (13). We have now characterized most of the genes
and enzymes for this pathway, including the gene for the first com-
mitted step encoding β-amyrin synthase (SAD1) (14–20; Fig. 1A).
In our initial mutant screen, we identified a total of 10 avenacin-
deficient A. strigosa mutants, two of which were sad1 mutants (109
and 610) (13). These two mutants both had single nucleotide
mutations resulting in premature termination of translation and
mRNA degradation (14), and so did not provide information about
amino acid residues important for enzyme function. The root
fluorescence screen is sensitive, and we subsequently extended this
screen to identify a further 82 avenacin-deficient A. strigosamutants
(15). Of these new mutants, 16 accumulated elevated levels of OS
and were identified as candidate sad1 mutants (21).
Here, we analyze this suite of 16 mutants and identify four with
predicted amino acid changes that make stable mutant SAD1
protein. Characterization of these mutant SAD1 variants led us to
identify two amino acid residues that are critical for SAD1 function.
One of these amino acids is a cysteine residue within the active site
that is critical for cyclization. Surprisingly, mutation at a different
residue (S728F) converted SAD1 into an enzyme that makes tet-
racyclic (dammarane) instead of pentacyclic products. When
expressed in yeast, this mutant SAD1 variant preferentially cyclizes
dioxidosqualene (DOS) rather than OS, giving epoxydammaranes.
Mutation of the equivalent amino acid residue of AtLUP1, an
Arabidopsis thaliana triterpene synthase that normally cyclizes OS to
pentacyclic products, similarly resulted in the generation of tetra-
cyclic triterpenes as the major cyclization products and preferential
generation of DOS-derived epoxydammaranes in yeast. This resi-
due is therefore critical for the generation of pentacyclic rather than
tetracyclic products and also appears to be a “substrate specificity
switch” in both monocot and dicot triterpene synthases.
Our discoveries provide new insights into triterpene cyclization
and reveal hidden functional diversity within the triterpene syn-
thases. They open up opportunities to engineer novel oxygenated
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triterpene scaffolds by manipulation of the precursor supply. Our
results further illustrate the power of using a forward genetics
approach to identify residues that are critical for the stability and
functional diversification of triterpene synthases.
Results
Identification of Mutant SAD1 Protein Variants. The avenacin-deficient
A. strigosa mutants were generated by using the chemical mutagen
sodium azide (13), which causes single-base substitutions, usually
from guanine to adenine (22, 23). DNA sequence analysis of the
Sad1 gene in each of the 16 new candidate sad1 mutants (21)
revealed single-point mutations in each case, the majority of which
involved guanine-to-adenine transitions as expected. The mutants
could be divided into three categories (Table 1)—those with pre-
dicted premature termination of translation mutations (as for the two
original sad1 mutants 109 and 610) (14); those with mutations at
intron-exon boundaries that may give rise to splicing errors; and those
with predicted amino acid substitutions.
We then assessed the sad1 transcript levels in RNA from the root
tips of these mutants by RT-PCR. The four new mutants with
predicted premature termination of translation codons (Table 1),
like 109 and 610 (14), had substantially reduced transcript levels
(Fig. 1B), most likely due to nonsense-mediated mRNA decay (24).
As expected, Western blot analysis using polyclonal antisera specific
for SAD1 (16) failed to detect cross-reacting protein in protein
preparations from the roots of these mutants (SI Appendix, Fig.
S1A). Transcripts were clearly detectable in the four predicted
splice site mutants (Fig. 1C and SI Appendix, Fig. S2), but further
examination by RT-PCR analysis across the mutation sites revealed
exon deletions (SI Appendix, Fig. S3). Protein that cross-reacted
with the SAD1 antisera was also undetectable in these mutants (SI
Appendix, Fig. S1B). These deletions may result in the formation of
misfolded proteins that are targeted for degradation (25).
The transcript levels for the seven mutants with predicted amino
acid substitutions were unaltered (Fig. 1D). Western blot analysis
revealed a protein of the same molecular mass as SAD1 in root
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Fig. 1. Characterization of sad1 mutants. (A) Biosynthesis of phytosterols and avenacin A-1 in oat. (B–D) RT-PCR analysis of mutant sad1 transcript levels in
mRNA extracted from the roots of wild-type (WT) oats and predicted premature termination of translation (B), splicing error (C), and amino acid substitution
(D) mutants (Table 1). The oat glyceraldehyde-3-phosphate dehydrogenase gene (GAPDH) was used as a control. (E) Analysis of protein extracts from root tips
of WT and mutant oat lines. (Left) Replicate gel stained with InstantBlue showing protein loading. (Right) Western blot analysis of extracts from predicted
amino acid substitution mutants probed with antisera raised against SAD1. A single band of ∼86 kDa corresponding to full-length SAD1 protein is present in
the WT and mutants 358, 384, and 1023. (F) Locations of point mutations in sad1mutants. A schematic of the WT Sad1 gene is shown at the top in red. Exons
are represented by boxes and introns by lines. The location of each mutation within the gene is indicated by a vertical line.
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extracts from three of these mutants (358, 384, and 1023) (Fig. 1E).
The mutations in the remaining four mutants are located in regions
that are likely to be important for protein structure and presumably
lead to unstable proteins that are degraded (SI Appendix, Fig. S4). A
schematic summarizing the nature and locations of all of the sad1
mutations is shown in Fig. 1F.
Conversion of S728 to F Results in the Formation of Tetracyclic Instead of
Pentacyclic Triterpenes in Planta. We next examined the triterpene
content of extracts from the root tips of seedlings of A. strigosa
mutants 358, 384, and 1023. We expected to see loss of the SAD1
cyclization product β-amyrin with associated accumulation of the
precursor OS. This result is indeed what we observed for the pre-
viously characterized sad1 mutant 109, a predicted premature ter-
mination of a translation mutant that does not produce SAD1
protein; also for mutant 358, suggesting that this mutant SAD1
variant is inactive (Fig. 2A and SI Appendix, Fig. S5). Surprisingly,
however, a new compound was observed in root extracts of mutants
384 and 1023 that was not present in extracts from the wild-type or
sad1 mutants 109 and 358 (Fig. 2A and SI Appendix, Fig. S5). The
new compound had an elution profile and mass spectrum identical
to dammaranediol-II (DM) (Fig. 2A and SI Appendix, Figs. S6 and
S7). DM was not detectable in wild-type root extracts by GC-MS,
although a more polar minor peak with an elution profile and mass
spectrum consistent with that of epoxydammarane (epDM) was
observed. Accumulation of DM in mutants of 384 and 1023 implies
specificity of the downstream avenacin pathway enzymes for the
β-amyrin scaffold.
Ginseng and other medicinal plants accumulate biologically
active epoxydammarane saponins at levels as high as 5%, but the
biosynthetic origin of the oxacyclic triterpenoid scaffold is
not known (26). Stereoisomers of 2-epoxydammarane have been
identified as cyclization products generated by the A. thaliana
mixed product triterpene synthase AtLUP1 in yeast when fed
with exogenous DOS (26). Although small peaks with similar
elution times to epDM were observed in the mutant extracts, we
were unable to detect epDM in these lines by GC-MS. Collectively,
these data indicate that the S728F mutation results in a change in
product specificity, converting SAD1 into an enzyme that yields
primarily tetracyclic rather than pentacyclic cyclization products.
Table 1. Sequence analysis of sad1 mutants
Mutant Mutation event Predicted amino acid change
Premature termination of translation:
A1 G1912A Tyr-165 Stop*
B1 G1912A Tyr-165 Stop*
109 G3417A Tyr-380 Stop
610 G1912A Tyr-165 Stop*
1146 G4169A Tyr-471 Stop
1293 G39A Tyr-13 Stop
Predicted splicing errors:
110 G6689A —
225 G3302A —
589 G3914A —
1001 G4365A —
Predicted amino acid substitutions:
297 G3939A Glu-419 Lys
358 G5234A Cys-563 Tyr
384 C7249T Ser-728 Phe†
532 G549A Gly-121 Glu
599 G2809A Gly-277 Glu
1023 C7249T Ser-728 Phe†
1217 G2025A Gly-203 Glu
*Identical mutation (G1912 → A). Although mutants A1, B1, and 610 all have
a mutation at G1912, these mutants were isolated from different M2 fam-
ilies and so represent independent mutation events.
†Identical mutation (C7249 → T). Although mutants 384 and 1023 have both
undergone a cytidine to thymidine change at C7249, these mutants were iso-
lated from different M2 families and so represent independent mutation events.
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Fig. 2. Effects of mutations on cyclization. Analysis was carried out by GC-MS.
Total ion chromatograms (TIC) are shown. (A) Analysis of oat root tip extracts
from theWT and sad1mutants 109, 358, 384, and 1023. (B) Analysis of extracts
from yeast expressing theWT SAD1 protein or the S728F SAD1mutant variant.
(C) β-amyrin, cycloartenol, and dammarenediol-II standards. BA, β-amyrin; CA,
cycloartenol; ERG, ergosterol.
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Heterologous Expression of the S728F SAD1 Mutant Variant in Yeast.
We then expressed the S728F SAD1 variant in yeast. cDNAs
encoding the wild-type SAD1 protein and the mutant SAD1 variant
were cloned into the yeast expression vector pYES2 under the
control of a galactose-inducible promoter, expressed in the yeast
strain GIL77 (gal2 hem3-6 erg7 ura3-167) (27) (SI Appendix, Fig.
S8), and yeast extracts were analyzed by GC-MS (Fig. 2B). β-Amyrin
was the major triterpene product detected when the wild-type
SAD1 protein was expressed in yeast. epDM was also detected as
a minor product (Fig. 2B). The S728F SAD1 mutant variant
produced small amounts of β-amyrin by comparison. Unexpectedly,
however, this variant generated a major peak that appeared to
correspond to epDM, with only trace amounts of DM (Fig. 2B and
SI Appendix, Fig. S9). DOS was also clearly detectable in extracts
from yeast expressing the SAD1 mutant variant but not in those
from the empty vector control or expressing the wild-type SAD1
protein. Thus, in yeast, the SAD1 mutant enzyme appears to pref-
erentially cyclize DOS rather than OS, yielding predominantly
epDM rather than DM (Fig. 3B). Accumulation of DOS in yeast
expressing the SAD1 mutant variant may be an equilibrium effect
due to pull through by DOS cyclization and could be suggestive of
metabolome formation.
To confirm the identity of the putative epDM cyclization product,
we grew a large-scale (1 L) culture of the yeast strain expressing the
S728F SAD1 mutant variant and purified ∼2 mg of this compound
(Methods). The purified triterpene was examined by 1H-NMR
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Fig. 3. Cyclization reactions carried out by the WT and mutant triterpene synthases from oat and A. thaliana. (A) The WT SAD1 protein first converts OS to the
tetracyclic dammarenyl cation and then traverses through a series of cations to give the oleanyl cation. The final step is the deprotonation of the oleanyl cation and
the release of β-amyrin (BA). In contrast, the S728F SAD1 variant catalyses an alternative cyclization reaction along the path indicated to give tetracyclic products. This
mutant cyclase can accept both OS and DOS as substrates, cyclizing them to DM and epDM, respectively. Accumulation of OS can lead to reacceptance of OS as a
substrate by endogenous squalene epoxidase, resulting in transformation of OS into DOS. TheWT SAD1 enzyme is also able to accept DOS and cyclize it to epDM, but
to a much lesser extent than the S728F SAD1 variant (∼6% of total cyclic products in oat and ∼3% of total cyclic products in yeast). (B) The cyclization reactions
catalyzed by WT ATLUP1 and the ATLUP1-T729F variant are shown. WT AtLUP1 is also able to accept DOS, cyclizing it to 2-epDM epimers as opposed to the single
epimer observed for SAD1. For AtLUP1–T729F, cyclization is predominantly DOS-mediated.
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spectroscopy at 400 MHz in CDCl3 solution (SI Appendix, Figs. S10
and S11). C-24S or C-24R epimers of the epoxydammaranes can be
distinguished by comparing the 1H-NMR chemical shifts of H-24,
Me-26, and Me-27 positions. Between C-20 and C-24, four different
combinations of configurations are possible. Molecules with
20R, 24R configuration are not known in nature. Three possible
configuration pairs (20S, 24S; 20R, 24S; 20S, 24R) are known to
occur in natural products; chemical shifts of assignable resonances
are listed in SI Appendix, Table S1. Because epDM, which is made
together with DM, has 20S configuration, it was anticipated to
maintain the S configuration at C-20. Chemical shifts at the di-
agnostic protons (H-24, Me-26, Me-27) confirmed epDM has
20S, 24S configuration. Chemical shifts and coupling constants at
H-24 vary dramatically for molecules with locally diastereomeric
configurations at C-20 and C-24. For example, epDMwith 20R, 20S,
at H-24 δ 3.73 (dd, J = 7.7, 6.9) was similar to the skeleton with
20S, 24R, at H-24 δ 3.73 (dd, J = 7.5, 7.5). For an arrangement with
both stereocenters S, H-24 appeared at δ 3.639 (dd, J = 10.1, 5.3), a
signal similar to that of the yeast-derived epDM [H-24 δ 3.64 (dd,
J = 9.9, 5.4)]. Based on this shift and coupling data, together with
other spectral attributes, the epDM product generated by the S728F
mutant variant of SAD1 was assigned the configuration 20S, 24S
and designated as (3S, 20S, 24S)-20,24-epoxydammarane-3,25-diol
(Fig. 3A).
Homology Modeling. To further investigate the likely impact of the
amino acid substitutions that we had observed on SAD1 stability
and function, we generated a homology model of SAD1 by using
the human lanosterol synthase crystal structure (28) as a template.
The locations of the seven predicted SAD1 amino acid substitu-
tions are shown in Fig. 4B. The C563Y mutation in line 358 results
in stable but inactive protein (Figs. 1 and 2). This mutation affects
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Fig. 4. Effects of mutations on protein structure and function. (A) Selected regions of 13 functionally characterized oxidosqualene cyclases from diverse
organisms were aligned and annotated according to known protein structure–function relationships. Conserved residues involved in substrate entry, reaction
initiation, and cation stabilization are shown in orange, yellow and gray, respectively. Red diamonds indicate the positions of the mutations in A. strigosa
mutants 358, 384, and 1023. (B) Location of the amino acid substitutions mapped onto a homology model of SAD1. Mutations are shown as red spheres;
mutations that still yield full-length SAD1 protein (C563Y, S728F) are indicated by asterisks. Amino acid residues involved in initiation of cyclization (yellow),
substrate entry (orange), and stabilization of cation intermediates (light gray) are indicated. The QW motifs involved in protein stability are shown as purple
helices, and detergent molecules that suggest how the enzyme is orientated in the membrane are shown as dark gray spheres. The table shows the amino
acid change in each of the sad1 mutants, their location in the tertiary structure, and the degree of amino acid conservation at each of these positions across
diverse oxidosqualene cyclases. (C) sad1 mutant 358 has a mutation at Cys563 (red), a residue that is hydrogen bonded to the catalytic aspartate (D484).
Hydrogen bonds are shown by dashed lines. The substrate is shown in green. (D) sad1mutants 384 and 1023 both have a mutation at Ser728 (red), which is in
close proximity to residues involved in substrate access (orange) and Phe725 (purple), involved in stabilization of the tetracyclic C-20 cationic intermediate.
Cation–π interactions are shown by gray dashed lines.
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a residue close to the catalytic aspartate D484 of the conserved
DCTAE motif (Fig. 4A). This conserved aspartate has been im-
plicated in oxidosqualene cyclase function in Euphorbia tirucalli
β-amyrin synthase (7). C485 (Fig. 4C) is known to be required
for the function of the oxidosqualene cyclase lanosterol syn-
thase in Saccharomyces cerevisiae (29). C563 has been pro-
posed to have a role in initiation of cyclization based on its
proximity to D484, following the determination of the human
lanosterol synthase crystal structure (28), but its function has
not been tested. The C563Y substitution introduces a bulky
tyrosine residue that is likely to interfere with the hydrogen
bonding interaction critical for lowering the pKa of D484 to
facilitate protonation of the epoxide group (Fig. 3C) (30). We
predict that this substitution will inhibit reaction initiation,
which would inactivate cyclization.
The wild-type SAD1 protein converts OS to the pentacyclic cy-
clization product β-amyrin through a series of cationic intermediates
(Fig. 3A). Protein modeling and docking analysis predict that in the
S728F variant, the aromatic side chain of the newly introduced
phenylalanine together with that of F725 sandwich the carboca-
tionic center of the dammarenyl cation (Fig. 4D). As a result, ring
expansion of the dammarenyl cation is likely to be compromised,
giving rise to formation of a truncated tetracyclic OS cyclization
product (Fig. 3A). This product is presumably converted to the diol
DM by interception of the C-20 cation by a water molecule. The
wild-type SAD1 protein is able to generate low levels of epDM in
oat and in yeast (Fig. 2 A and B), suggesting that although OS is its
preferred substrate, it is capable of using DOS. In contrast, the
S728F mutant SAD1 variant preferentially accepts DOS as a sub-
strate when expressed in yeast and cyclizes this to epDM (Fig. 3B).
As speculated in Shan et al. (26), side-chain rotation of the distal
epoxide to the carbocation at C-20 may enable movement of a
positive charge from carbon to oxygen and attack of a nearby water
molecule to give an alcohol at C-25. The epoxide-containing side
chain of the dammarenyl cation is therefore free to rotate within
the active site to participate in cyclization. S728 is located close
to a loop containing I554, T260, and Y264. This loop is believed
to block the opening to the substrate access channel and undergo
a conformational change to allow substrate entry to the active
site (Fig. 4D). The S728F amino acid substitution may alter
the hydrogen-bonding network of this loop and control access of
the two substrates (OS and DOS) into the active site. However,
further experiments are required to investigate this mecha-
nism in detail. The addition of water in triterpene cyclization
is known for the triterpene synthases PgPNA, AtLUP1, and
AtPEN1 (ARAB) (31–35). Unlike AtLUP1, which makes two
stereoisomers of epDM (20R, 24S and 20S, 24S), S728F accu-
mulates only 20S, 24S-epDM in a highly stereospecific manner.
Cyclization of the side chain of DOS occurs in a manner con-
sistent with cation quenching by a positioned water molecule,
resulting in a reaction that is more stereospecific in S728F than
in the AtLUP1 enzyme.
We next investigated the effects of amino acid substitution at
the corresponding position in the A. thaliana triterpene synthase
AtLUP1 (Thr729; Fig. 4A and SI Appendix, Fig. S12). Wild-type
AtLUP1 and a mutated version in which Thr729 had been
converted to phenylalanine (T729F) were expressed in yeast.
Wild-type AtLUP1 produced the OS-derived pentacyclic tri-
terpenes lupeol and lupanediol as the major cyclization prod-
ucts, and also the epoxydammarendiols epDM (20R, 24S) and
17,24-expoybaccharane diol from DOS as minor products (Figs.
3B and 5). Interestingly, the AtLUP1-T729F mutant yielded pri-
marily epoxydammarendiol products (Figs. 3B and 5 and SI Ap-
pendix, Figs. S13 and S14). Thus, the T729F mutation in AtLUP1
leads to a change in product specificity from pentacyclic to tetra-
cyclic triterpenes, and also to preferential cyclization of DOS in-
stead of OS in yeast as seen for the SAD1 S728F mutant variant.
As seen for SAD1 S728F, yeast strains expressing the mutant form
of AtLUP1 also accumulated elevated levels of DOS (SI Appendix,
Fig. S15). The S728F SAD1 mutant enzyme shows high stereo-
selective cyclization of DOS to the epDM-20S, 24S epimer, whereas
AtLUP1 is less selective, generating two epimers and other addi-
tional minor products. Elucidation of the crystal structures of the
wild-type and mutant forms of these enzymes may in the future
enable the exact nature of this control to be understood in
more detail.
Discussion
In tritepenoid biosynthesis, cyclization of OS is the key step that
determines the nature of the triterpene scaffold. The enzymes
that catalyze this process—triterpene synthases—belong to
multigene families in plant genomes. Here, we have shown that a
single-point mutation that causes an amino acid substitution
close to the active site dramatically alters product specificity in
both SAD1 and LUP1, so uncovering hidden functional diversity
in these triterpene synthases. It is conceivable that nature ex-
plores alternate modes of cyclization through such single muta-
tional steps, as has been suggested for diterpene synthases (36–43).
A dedicated cyclase that makes epDM as its major product has not
been reported before our work to our knowledge. Triterpene gly-
cosides based on the DM and epDM skeletons have important
pharmaceutical and antibacterial properties (44–46). Our results
open up the possibility of manipulating both the nature of the
precursor and the product specificity of the cyclization process
for the production of diverse and novel triterpenes. They further
demonstrate the power of forward genetics screens in plants for
elucidating the enzymatic mechanisms of this versatile and fas-
cinating group of enzymes.
Methods
Plant Material. Wild-type and mutant A. strigosa lines were grown as de-
scribed (13). Transcript, protein, and triterpene analysis were carried out by
using root tips (terminal 0.5 cm) from 3-d-old seedlings, and genomic DNA
was extracted from 6-d-old seedlings.
DNA, RNA, and Protein Analysis. Genomic DNA was isolated from 6-d-old
seedlings of A. strigosa by using the DNeasy Plant Mini kit (Qiagen). The
wild-type and mutant forms of the Sad1 gene were amplified in four seg-
ments. Purified DNA segments from each of the sad1 mutants were se-
quenced by using sets of primers along the length of the Sad1 gene, and
each mutant was sequenced to at least twofold coverage. Primers used for
Sad1 amplification and sequencing are shown in SI Appendix, Table S2.
Genomic DNA samples from each mutant were sent for Diversity Array
Technology (DArT) analysis (Diversity Arrays Technology Pty Ltd) to confirm
that each mutant line was independent (47).
For analysis of transcripts in oats, total RNAwas extracted from 0.5-cm root
tips of 3-d-old oat seedlings by using TRI-REAGENT (Sigma catalog no. T9424)
and the extract was treated with DNase I (Roche). For RT-PCR, cDNA was
synthesized by using 1 μg of DNase-treated RNA. First-strand cDNA synthesis
was carried out by using SuperScript II Reverse Transcriptase (Invitrogen)
according to the manufacturer’s instructions, and cDNA was amplified by
PCR. For Northern blot analysis, 10 μg of total RNA was used. RNA was
separated on a 1.2% (wt/vol) agarose/0.25 M formaldehyde gel and trans-
ferred to a Hybond-N+ nylon membrane (Amersham) overnight. cDNA
probes were labeled with 32P-dCTP by using the Rediprime II Random Prime
Labeling Kit (Amersham). Hybridizations were carried out overnight at 65 °C
in 10 mL of Church Buffer containing 0.1 mg/mL salmon sperm DNA (Sigma)
and 50 μL of 32P-dCTP labeled probe. The membrane was exposed to a BAS-
IIIS imaging plate (Fuji) overnight and imaged by using a Typhoon 9200
Variable Mode Imager (Amersham).
For protein and immunoblot analysis of oat root protein, total protein was
extracted from 0.5-cm root tips of 3-d-old oat seedlings. Root tips were ground
in protein extraction buffer [50 mM Tris·HCl pH 7.5, 150 mMNaCl, 5 mM EDTA,
10% (vol/vol) glycerol, 1% (wt/vol) PVPP, 1% (vol/vol) Triton X-100 (Boehringer
Mannheim), 1× Complete protease inhibitor (Roche)] for 1 min with a plastic
pestle followed by incubation at 4 °C for 2 h. Proteins were denatured, sep-
arated on NuPAGE gels (4–12% acrylamide gradient) (Invitrogen), and blotted
onto nitrocellulose membranes (Bio-Rad) by using the manufacturer’s pro-
tocol. Membranes were probed with anti-SAD1 antisera (1:10,000 dilution)
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(16) followed by detection with a goat anti-rat IgG horseradish peroxidase-
labeled secondary antibody (Sigma-Aldrich) according to the manufacturer’s
protocol.
Extraction and Analysis of Triterpenes from Oat Roots. The triterpene content of
oat root tipswas analyzedby TLC andGC-MS. Root tips (∼50per line)wereground,
mixed with 0.5 mL of saponification reagent [20% (wt/vol) KOH in 50% (vol/vol)
ethanol], and incubated at 65 °C for 2 h before extraction with an equal
volume of hexane. The extraction step was repeated twice more to maxi-
mize triterpene recovery. The extract was then dried down, and the residue
dissolved in 500 μL of hexane. For rapid qualitative analysis, extracts were
run on TLC plates (Silica gel on Al foil, 10 cm × 5 cm, FLU.K.A, catalog no.
70644) by using a hexane:ethyl acetate (6:1) solvent system. Compounds
were visualized by spraying the plates with acetic acid: H2SO4: p-anisalde-
hyde (48:1:1 vol/vol) and heating to 120 °C for 5 min on a TLC plate heater.
For GC-MS analysis, 100-μL aliquots of hexane extract were dried down and
the residues were resuspended in 100 μL of Tri-Sil Z reagent (Sigma, catalog
no. 92718) before incubating at 65 °C for 30 min in a dry heat bath. Samples
were run on either a HP-5MS column (30 m × 0.25 mm i.d., 0.25-μm film)
(Agilent) or a ZB-5HT column (35 m × 0.25 mm i.d., 0.10-μm film) (Phe-
nomenex) by using an Agilent 7890B GC machine. The injector port, source,
and transfer line temperatures were set at 250 °C; an oven temperature
program from 80 °C (2 min) to 290 °C (30 min) at 20 °C/min was used. The
carrier gas was helium; the flow rate was 1.2 mL/min. Samples were injected
in splitless mode with either a 1-μL or a 3-μL sample volume. The output was
used to search the NISTv8 library to assign identity to peaks in the GC-MS
traces. Product abundance was calculated as the percentage of total cyclic
products using integrated peak areas. All experiments were repeated to
confirm reproducibility of the triterpene profiles of the wild-type and
mutant samples.
Triterpene Standards. Dammarenediol-II (catalog no. CFN99476, 98% HPLC
pure) was purchased from Wuhan ChemFaces Biochemical Co. Ltd, China,
and β-Amyrin and cycloartenol from Extrasynthese. The standards were
dissolved and diluted to 0.5 mg/mL in hexane before derivatization
and GC-MS.
AtLUP1 Cloning and Site-Directed Mutagenesis. AtLUP1 (AT1G78970)-ORF was
amplified from total cDNA of young A. thaliana (Col-0) seedlings by PCR
using Gateway primers (SI Appendix, Table S2) and cloned into pDONOR207.
The T729F mutation was created by site-directed mutagenesis using
pDONOR207:AtLUP1 plasmid as the template. The oligonucleotide design strat-
egy and conditions for PCR amplification followed those described (48). The
oligonucleotides used for site-directed mutagenesis are listed in SI Appendix,
Table S2.
Yeast Cloning and Expression. All cloning and expression analysis was carried
out in the yeast strain GIL77 (gal2 hem3-6 erg7 ura3-167) (32). Expression
vectors were constructed by using in vivo homologous recombination in yeast.
The ORFs of the wild-type Sad1 gene, AtLUP1 (AT1G78970), and mutant var-
iants were amplified from pDONOR207 entry vectors by using the oligonu-
cleotides for yeast cloning shown in SI Appendix, Table S2. Each primer
contained a region that overlapped with the pYES2 vector sequences (the 5′
end of the forward primer overlapped with the GAL1 promoter sequence, and
the 5′ of the reverse primer with the CYC1 terminator sequence). The 3′ ends
of the primers matched the beginning and end of the Sad1 ORF. The ORFs of
the wild-type and mutant lines were amplified by using these primers, and the
PCR fragments obtained were cotransformed into GIL77 strain along with
XbaI/HindIII-linearized pYES2 vector. Yeast transformation was performed by
using standard protocols (Yeastmaker Yeast transformation system 2, Clontech
Laboratories). This resulted in in vivo recombination between the pYES2 vector
and the Sad1 ORFs. Plasmids were recovered from yeast, transformed into
E. coli, and checked by sequencing.
For expression analysis, yeast strains were grown at 28 °C in 5-mL cultures
in selective medium [SD-URA+ 2% (wt/vol) glucose + supplements] until
saturation (∼2 d). The supplements used were as follows: ergosterol (Fluka),
20 μg/mL; hemin (Sigma-Aldrich), 13 μg/mL; and Tween-80 (Sigma-Aldrich),
5 mg/mL. Cells were then pelleted, washed in ddH2O, transferred to in-
duction medium [SD-URA + 2% (wt/vol) galactose], and incubated for a
further 2 d to allow accumulation of triterpenes. They were then pelleted
and washed once with ddH2O before triterpene extraction as described for
oat roots.
For protein analysis, yeast cells were resuspended in protein extraction
buffer [50mMTris·HCl pH7.5, 150mMNaCl, 5mMEDTA, 10% (vol/vol) glycerol,
1% (wt/vol) PVPP, 1% (vol/vol) Triton X-100 (Boehringer Mannheim), 1×
Complete protease inhibitor (Roche)] and lysed by using a French press
(with two passes at 1125 p.s.i., 4 °C). The preparations were then in-
cubated on ice for 2 h and then centrifuged at 21,130 × g for 20 min. The
supernatants were used for protein and Western blot analysis as described
previously (16).
Purification and Structural Elucidation of (3S, 20S, 24S)-20,24-epoxydammarane-3,
25-diol. epDMwasextracted froma1-L cultureof a yeast transformant expressing
the SAD1 S728F variant. Cells were pelleted, round, and then extracted by using
themethods described above for oat roots. The organic residue was loaded onto
a silica gel column 10 cm long and 0.5 cm in diameter (LC60A35-70 μm;
Fluorochem) in a Pasteur pipette that had been preequilibrated with an ethyl
acetate:hexane (1:9) solvent system. The column was washed with 5–6 column
volumes of 1:9 ethyl acetate:hexane to remove oxidosqualene, dioxidosqualene,
and other nonpolar yeast components. Next, the solvent was switched in a step
gradient to 1:6 and then 1:4 ethyl acetate:hexane, and 0.5-mL fractions were
collected and analyzed by TLC. Fractions containing epDM were combined and
dried in a rotary evaporator. The purity of the compound was assessed by using
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Fig. 5. Total ion chromatograms of yeast extracts expressing the WT and
mutant triterpene synthases. In AtLUP1, lupeol and lupanediol are derived
from OS cyclization, whereas epDM isomers (20S, 24R and 20S, 24S) and 17,
24 epoxybaccharane diol are derived from DOS cyclization. For the SAD1
mutant variant S728F (384), the epDM isomer-20S, 24S is derived from DOS.
Peaks with red arrows indicate OS-derived cyclization products, and ones
with green indicate DOS-derived cyclization products.
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GC-MS. Through this process, we obtained ∼2 mg of the compound. To assign
configuration to epDM, we recorded 1H-NMR of epDM in CDCl3 at 400 MHz
(Bruker Avance III).
Homology Modeling and Sequence Alignments. For homology modeling of
SAD1, human lanosterol synthase was used as a template (PDB ID code;
1W6K) to generate a model using Modeler (49). The models obtained were
subjected to stereochemical validation by using Prosa II (50), Prove (51),
and Procheck (52). Models were visualized by using PyMOL (53). Protein
sequences were aligned by using Clustal W, and sequence features were
viewed and annotated manually using functional information available
for human lanosterol synthase (28).
The orientation and position of SAD1 relative to a virtual membrane were
predicted by using the PPM server (54). This approach allows the calculation
of the rotational and translational positions of transmembrane and pe-
ripheral proteins in membranes using their 3D structure as input. Hydro-
phobicity was calculated by using the TopPred II server (55).
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